Imagine a world where we could be vaccinated against degenerative diseases such as Alzheimer's and Parkinson's. This is the dream of Austrian company AFFiRiS who are developing customised vaccines with their patented AFFITOM®- technology targeting Alzheimer’s and Parkinson’s disease, as well as arthrosclerosis, hypertension, diabetes and other diseases. The company is focussed on diseases with urgent medical needs and attractive markets.

In the race to develop an effective and approved immunotherapy against Alzheimer’s, AFFiRiS wants to join the world's leading competitors.